MedImmune, wholly owned by AstraZeneca, has a growing pipeline of products in development for the prevention and treatment of RSV.
-
MedImmune's motavizumab is a monoclonal antibody for prevention of RSV... -
RSV is a negative-sense, enveloped RNA virus that infects the upper... -
Pre-term infants and those with chronic lung and congenital heart disease are... -
MedImmune, wholly owned by AstraZeneca, has a growing pipeline of products in...
